My watch list  

186 Current news about the topic biopharmaceuticals


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
WACKER Strengthens Biologics Business by Acquiring US-Based Plasmid DNA Manufacturer Genopis

Expansion of WACKER's portfolio as a contract manufacturer for the pharmaceutical industry


The Munich-based chemical company WACKER is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis Inc. from Helixmith Co Ltd, Seoul (South Korea) and Medivate Partners LLC, Seoul (South Korea). WACKER signed a corresponding agreement. WACKER will continue Genopis' ...


image description
Merck Invests in State-Of-The-Art Biotech Development Facility in Switzerland


Merck announced an investment of €250million in a new facility in Corsier-sur-Vevey, Switzerland – the Merck Biotech Development Center – dedicated to biotech development and manufacturing for clinical studies. Driven by the growth of the Healthcare business sector R&D pipeline, this investment ...


image description
Turbo-charging pharmaceutical biotechnology simulations

New simulation technology is designed to make the production of biopharmaceuticals more efficient, cost-effective and comprehensible


Demand for biopharmaceuticals is strong: biopharmaceutical active ingredients – in other words, genetically engineered drugs – accounted for seven of the ten top-selling medications in the world in 2018. And the proportion is set to rise, as biopharmaceuticals can be used to combat conditions ...


image description
Protagen Protein Services and BioAnalytix Merge

Create Global Analytic Service Partner for Biopharmaceuticals


Protagen Protein Services GmbH (PPS), a full-service contract research organization (CRO) in protein analytics and BioAnalytix Inc., a Cambridge(MA)-based specialized provider of advanced analytics in biologic development announced a merger that will transform the combined company into a leading ...


Lonza to Establish Strategic Biomanufacturing Base in China


Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be finalized ...


WACKER Invests in Jena Biotech Site


In Jena, the Munich-based chemical group WACKER has enhanced its production facilities for biopharmaceuticals – also known as biologics – with new equipment. Furthermore, an inspection by the Brazilian health authority ANVISA assessing the site’s quality standards was a major success. “In recent ...


PhoreMost completes $15M Series-A round to enter drug discovery

Investment to fund expansion of operations and progression of drug target pipeline


PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The investment will be used to expand operations on the Babraham Research Campus and progress several novel drug ...


WACKER Buys Dutch Biotechnology Plant


Wacker Chemie AG has acquired a Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines, plus the associated business, from SynCo Bio Luxembourg S.à.r.l.. For WACKER, maintaining SynCo’s existing customer relationships is a top priority. Moreover, WACKER is keeping ...


New international partnership promises great potential for next-generation biopharmaceuticals

New virus-free insect cell line


There are a multitude of challenges associated with the production of next-generation biopharmaceuticals and vaccines. The Austrian Centre of Industrial Biotechnology and the BOKU - University of Natural Resources and Life Sciences, Vienna together with the Boyce Thompson Institute (BTI) Ithaca, ...


GE Healthcare acquires bioprocessing start-up

Obtaining nanofiber-based platform purification technology for biopharmaceutical production


GE Healthcare has completed the acquisition of Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify’s technology, FibroSelect, is complementary to the bead resins and chromatography membranes used today ...


Page 1 From 19
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE